1. Clinical Course of Three Postoperative Symptomatic COVID-19 Cases in Patients After Lung Lobectomy.
- Author
-
Stoleriu MG, Gerckens M, Hetrodt J, Heiß-Neumann M, Koch I, Stacher-Priehse E, Dinkel J, Behr J, Grützner U, and Hatz R
- Subjects
- Adenocarcinoma pathology, Adenocarcinoma surgery, Aged, COVID-19, Carcinoma, Squamous Cell pathology, Carcinoma, Squamous Cell surgery, Coronavirus Infections etiology, Coronavirus Infections therapy, Cross Infection etiology, Cross Infection therapy, Female, Humans, Lung Neoplasms pathology, Male, Middle Aged, Pandemics, Pneumonia, Viral etiology, Pneumonia, Viral therapy, Postoperative Complications etiology, Postoperative Complications therapy, SARS-CoV-2, Thoracoscopy adverse effects, Thoracotomy adverse effects, Betacoronavirus, Coronavirus Infections diagnosis, Cross Infection diagnosis, Lung Neoplasms surgery, Pneumonectomy adverse effects, Pneumonia, Viral diagnosis, Postoperative Complications diagnosis
- Abstract
The novel coronavirus disease 2019 is a highly contagious viral infection caused by the severe acute respiratory syndrome coronavirus 2 virus. Its rapid spread and severe clinical presentation influence patient management in all specialties including thoracic surgery. We report 3 cases of coronavirus disease 2019 occurring in patients shortly after thoracotomy and thoracoscopy procedures, illustrating the imminent threat of severe acute respiratory syndrome coronavirus 2 infection for thoracic surgery patients., (Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF